Inhibition of mammalian 5-lipoxygenase by 2-benzylaminophenols. 1988

D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
Beecham Pharmaceuticals, Research Division, Biosciences Research Centre, Epsom, Surrey, UK.

A number of 2-benzylaminophenols, prepared from the corresponding 2-aminophenols by reductive alkylation, have been identified as highly potent inhibitors of 5-lipoxygenase with IC50 values in the nanomolar range. Most compounds were also shown to inhibit the release of the peptidoleukotrienes when administered intraperitoneally in a rat model of peritoneal anaphylaxis. Two compounds evaluated for their effects on anaphylactic contractions in isolated human lung were shown to attenuate the leukotriene-induced component of the response.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008832 Microchemistry The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000627 Aminophenols Phenols substituted in any position by an amino group. Hydroxyanilines
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001091 Arachidonate Lipoxygenases Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . Arachidonic Acid Lipoxygenase,Lipoxygenase, Arachidonic Acid,Lipoxygenases, Arachidonate
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis
D016859 Lipoxygenase Inhibitors Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. 5-Lipoxygenase Inhibitor,Lipoxygenase Inhibitor,12-Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors,Arachidonate 12-Lipoxygenase Inhibitors,Arachidonate 15-Lipoxygenase Inhibitors,Arachidonate 5-Lipoxygenase Inhibitors,Inhibitors, Lipoxygenase,12 Lipoxygenase Inhibitors,12-Lipoxygenase Inhibitors, Arachidonate,15 Lipoxygenase Inhibitors,15-Lipoxygenase Inhibitors, Arachidonate,5 Lipoxygenase Inhibitor,5 Lipoxygenase Inhibitors,5-Lipoxygenase Inhibitors, Arachidonate,Arachidonate 12 Lipoxygenase Inhibitors,Arachidonate 15 Lipoxygenase Inhibitors,Arachidonate 5 Lipoxygenase Inhibitors,Inhibitor, 5-Lipoxygenase,Inhibitor, Lipoxygenase,Inhibitors, 12-Lipoxygenase,Inhibitors, 15-Lipoxygenase,Inhibitors, 5-Lipoxygenase,Inhibitors, Arachidonate 12-Lipoxygenase,Inhibitors, Arachidonate 15-Lipoxygenase,Inhibitors, Arachidonate 5-Lipoxygenase

Related Publications

D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
September 1985, The Journal of biological chemistry,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
November 1985, FEBS letters,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
January 2017, Biochemical pharmacology,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
November 1989, Agents and actions,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
September 1986, Chemical & pharmaceutical bulletin,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
August 1988, Biochemical pharmacology,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
September 1984, Biochemical pharmacology,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
May 1989, Biochemical pharmacology,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
July 2011, Pharmaceutical biology,
D R Buckle, and J Bumstead, and G D Clarke, and K A Foster, and H Parr, and J F Taylor, and V E Thody, and R A Webster
November 2006, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!